APH vs CSBR · P/E 40, rev $23.09B vs P/E 16, rev $56.9M
Amphenol Corporation (APH) versus Champions Oncology Inc (CSBR) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported CSBR revenue for 2025-04-30 was $56.9M. Net income was $4.7M. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
APH currently screens at market cap $170.77B and trailing P/E 39.9. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Not investment advice. Open the APH and CSBR stock pages for the full models.
Not investment advice.